IMUNON ($IMNN) posted quarterly earnings results for Q4 2025 on Tuesday, March 31st. The company reported earnings of -$1.29 per share, missing estimates of -$1.20 by $0.09. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $IMNN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMUNON Hedge Fund Activity
We have seen 7 institutional investors add shares of IMUNON stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 266,886 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,016,835
- SABBY MANAGEMENT, LLC removed 69,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $353,970
- RENAISSANCE TECHNOLOGIES LLC removed 48,913 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $250,923
- BAADER BANK AKTIENGESELLSCHAFT removed 21,583 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $110,720
- VANGUARD GROUP INC added 13,751 shares (+59.0%) to their portfolio in Q4 2025, for an estimated $52,391
- UBS GROUP AG removed 9,207 shares (-85.2%) from their portfolio in Q4 2025, for an estimated $35,078
- DRW SECURITIES, LLC added 3,803 shares (+6.9%) to their portfolio in Q4 2025, for an estimated $14,489
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
